Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (LMAT)
NASDAQ:LMAT
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.5Last Year’s EPS
0.44Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -20.91%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
LeMaitre Vascular reported strong financial performance with significant sales growth across key product lines and geographies. The expansion in China and improvement in gross margins highlight strategic progress. While there are pending regulatory approvals and potential tariff impacts, the company's positive guidance for 2025 and robust financial health indicate a strong outlook.Company Guidance
During the LeMaitre Vascular Q4 2024 Financial Results Conference Call held on February 27, 2025, various metrics and forward-looking guidance were discussed. The company reported a Q4 sales growth of 14%, operating income growth of 26%, and an EPS increase of 30%. Geographically, sales in the APAC region rose by 21%, EMEA by 18%, and the Americas by 12%. The company's sales force grew by 12% year-over-year to 152 representatives, with plans to expand to 165 by the end of 2025. Adjustments in the U.S. list prices led to actual worldwide price increases of 8%, 12%, and 9% for 2022, 2023, and 2024, respectively. For Q1 2025, a gross margin of 69.7% is anticipated, with operating expenses in Q4 2024 at $25.7 million, reflecting a 12% year-over-year increase. The company ended Q4 with $300 million in cash and securities, driven by net proceeds from a convertible offering and cash from operations. Looking forward, LeMaitre guides for 2025 full-year organic sales growth of 10%, a gross margin of 69.7%, operating income of $59.8 million, and an EPS of $2.24 per share.Strong Sales Growth
Q4 2024 featured a sales growth of 14%, with operating income up 26% and EPS up 30%. Sales growth was led by grafts, shunts, and catheters, with increases of 23%, 14%, and 12% respectively. Geographically, APAC sales were up 21%, EMEA 18%, and the Americas 12%.
Strategic Expansion in China
LeMaitre Vascular began shipping products from the new Shanghai office to Chinese customers, with sales in China up 48% in Q4. The company received Chinese XenoSure cardiac approval in December and plans to launch XenoSure in H2 2025.
Robust Financial Health
LeMaitre Vascular ended Q4 2024 with $300 million in cash and securities, an increase of $176 million in the quarter driven by net proceeds of the convertible offering and cash from operations.
Gross Margin Improvement
Q4 gross margin increased by 120 basis points year-over-year to 69.3%, driven by higher ASPs, direct labor efficiencies, and improved RestoreFlow Allograft yields.
Positive Guidance for 2025
The company is guiding for organic sales growth of 10%, operating income of $59.8 million (up 15%), and EPS of $2.24 per share (up 16%) for the full year 2025.
---
LMAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LMAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $99.66 | $91.62 | -8.07% |
| Oct 31, 2024 | $88.04 | $94.50 | +7.34% |
| Aug 01, 2024 | $85.74 | $84.50 | -1.45% |
| May 02, 2024 | $66.24 | $73.63 | +11.16% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Lemaitre Vascular (LMAT) report earnings?
Lemaitre Vascular (LMAT) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Lemaitre Vascular (LMAT) earnings time?
Lemaitre Vascular (LMAT) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LMAT EPS forecast?
LMAT EPS forecast for the fiscal quarter 2025 (Q1) is 0.5.
---